155 related articles for article (PubMed ID: 38445658)
1. Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
Hwang H; Kim JH; Ko E; Kim JY; Ko HK; Gwon DI; Shin JH; Kim GH; Chu HH
Br J Radiol; 2024 May; 97(1157):1038-1043. PubMed ID: 38445658
[TBL] [Abstract][Full Text] [Related]
2. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein.
Kim JH; Shim JH; Yoon HK; Ko HK; Kim JW; Gwon DI
Liver Int; 2018 Sep; 38(9):1646-1654. PubMed ID: 29436101
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
6. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors.
Xiao L; Liu Q; Zhao W; Pang H; Zeng Q; Chen Y; Zhao J; Mei Q; He X
Clin Radiol; 2018 Dec; 73(12):1056.e17-1056.e22. PubMed ID: 30224186
[TBL] [Abstract][Full Text] [Related]
7. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
9. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
Yang Z; Zou R; Zheng Y; Qiu J; Shen J; Liao Y; Zhang Y; Wang C; Wang Y; Yuan Y; Li K; Zuo D; He W; Liu W; Li B; Yuan Y
Eur Radiol; 2019 Nov; 29(11):5752-5762. PubMed ID: 30993438
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
Long J; Zheng JS; Sun B; Lu N
Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?
Zheng JS; Long J; Sun B; Lu NN; Fang D; Zhao LY; Du N
Clin Radiol; 2014 Jun; 69(6):e253-63. PubMed ID: 24581962
[TBL] [Abstract][Full Text] [Related]
12. Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.
Zhao Y; Duran R; Chapiro J; Sohn JH; Sahu S; Fleckenstein F; Smolka S; Pawlik TM; Schernthaner R; Zhao L; Lee H; He S; Lin M; Geschwind JF
J Gastrointest Surg; 2016 Dec; 20(12):2002-2009. PubMed ID: 27714643
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis.
Li L; Cheng N; Huang X; Weng X; Jiao Y; Liu J; Guo W
World J Surg Oncol; 2022 Feb; 20(1):30. PubMed ID: 35109883
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
Li S; Li L; Li B; Wang W
Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
16. Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization.
Kim SH; Kim JH; Kim GH; Kim JH; Ko HK; Chu HH; Shin JH; Gwon DI; Ko GY; Yoon HK; Aljerdah S; Kim N
Eur Radiol; 2023 Dec; 33(12):8736-8744. PubMed ID: 37466704
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of transcatheter arterial chemoembolization combined with either
Li Y; Li H; Hu H; Yuan H; Zhao Y
J Cancer Res Ther; 2020; 16(7):1691-1697. PubMed ID: 33565518
[TBL] [Abstract][Full Text] [Related]
18. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study.
Tan Z; Lu J; Zhu G; Chen L; Wang Y; Zhang Q; Pan T; Wang J; Guo J; Teng G
Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1414-1422. PubMed ID: 34131776
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization in patients with hepatocellular carcinoma beyond Barcelona-Clinic Liver Cancer- B and portal vein tumor thrombosis: Experience from a tertiary care center.
Anand S; Pottakkat B; Raja K; Chandrasekar S; Satheesh S
Indian J Cancer; 2022; 59(3):325-329. PubMed ID: 33753610
[TBL] [Abstract][Full Text] [Related]
20. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Jeong Y; Yoon SM; Han S; Shim JH; Kim KM; Lim YS; Lee HC; Kim SY; Park JH; Lee SW; Ahn SD; Choi EK; Kim JH
PLoS One; 2015; 10(8):e0135298. PubMed ID: 26252472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
